E. Jennifer Edelman, MD, MHS, BS
Cards
About
Research
Publications
2024
ASSOCIATIONS BETWEEN REDUCTIONS IN DEPRESSIVE SYMPTOMS AND REDUCTIONS IN PAIN AND ANXIETY SYMPTOMS AND SUBSTANCE USE: EMULATION OF A RANDOMIZED TRIAL
Khan M, Acri M, Ban K, Scheidell J, Stevens E, Manandhar-Sasaki P, Charles D, Chichetto N, Crystal S, Gordan A, Marshall B, Edelman E, Justice A, Braithwaite R, Caniglia E. ASSOCIATIONS BETWEEN REDUCTIONS IN DEPRESSIVE SYMPTOMS AND REDUCTIONS IN PAIN AND ANXIETY SYMPTOMS AND SUBSTANCE USE: EMULATION OF A RANDOMIZED TRIAL. AJPM Focus 2024, 100258. DOI: 10.1016/j.focus.2024.100258.Peer-Reviewed Original ResearchUnhealthy alcohol useDepressive symptomsAnxiety symptomsIllicit opioid useOdds ratioAlcohol useVeterans Aging Cohort StudyPain symptomsConfidence intervalsTarget trial emulation frameworkElevated depressive symptomsAssociated with reductionsReducing depressive symptomsAging Cohort StudySubstance useOpioid useMultisite observational studyDepressive symptom reductionNext follow-up visitUS veteransReduce painFollow-up visitCohort studyAntidepressant medicationComparing individuals“Recovery is about change, so you have to change everything”: Exploring the evolution of recovery capital among women in substance use disorder treatment
Jadovich E, Viera A, Edelman E, Muilenburg J, Kershaw T. “Recovery is about change, so you have to change everything”: Exploring the evolution of recovery capital among women in substance use disorder treatment. SSM - Qualitative Research In Health 2024, 5: 100422. DOI: 10.1016/j.ssmqr.2024.100422.Peer-Reviewed Original ResearchSubstance use disorder treatmentRecovery capitalSecondary qualitative analysis of dataDisorder treatmentNon-clinical interventionsCommunity capitalSubstance use disordersSecondary qualitative analysisSubstance use disorder recoveryIndirect effects of treatmentExperiences of womenEffects of treatmentSubstance use researchRecovery capital frameworkAddiction researchQualitative analysis of dataStudy time pointsThematic analysisClinical pathwayParticipants' experiencesTreatment programsDisorder recoveryWomen's experiencesCapital frameworkCapital developmentImplementation of Opioid Safety Efforts: Influence of Academic Detailing on Adverse Outcomes Among Patients in the Veterans Health Administration.
Williams E, Frost M, Bounthavong M, Edmonds A, Lau M, Edelman E, Harvey M, Christopher M. Implementation of Opioid Safety Efforts: Influence of Academic Detailing on Adverse Outcomes Among Patients in the Veterans Health Administration. Substance Use & Addiction Journal 2024, 29767342241243309. PMID: 38634339, DOI: 10.1177/29767342241243309.Peer-Reviewed Original ResearchVeterans Health AdministrationAcademic detailingAll-cause mortalityInpatient admissionsED visitsHealth AdministrationVA electronic health recordOpioid poisoningEmergency departmentOdds of all-cause mortalityElectronic health recordsRates of inpatient admissionsAssociated with decreased all-cause mortalityPatients prescribed long-term opioidsInterrupted time series analysisIncreased inpatient hospitalizationsOpioid-related outcomesOverdose prevention initiativesLong-term opioidsIncreasing incidence ratesLong-term opioid prescriptionsPatient-level dataObservational cohort of patientsHealth recordsAD implementationDiscordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke.
Bernstein S, Yager J, Sigel K, Porter E, Do T, Payne E, Bold K, Ledgerwood D, Edelman E. Discordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke. Journal Of Addiction Medicine 2024 PMID: 38606851, DOI: 10.1097/adm.0000000000001302.Peer-Reviewed Original ResearchNicotine replacement therapyHuman immunodeficiency virusTobacco use disorderAntiretroviral therapyReplacement therapyTobacco useImmunodeficiency virusCoverage of antiretroviral therapyInsurance coverageSecondary analysis of dataUse disorderManaged care planOut-of-pocketMandated insurance coverageCare planningEfficacy of antiviralsRandomized clinical trialsPharmacy benefit managersInsurance barriersMedication prescriptionsSecondary analysisTracking formParticipation AssessmentAntiviral medicationsPWHPriorities for HIV and chronic pain research: results from a survey of individuals with lived experience
Robinson-Papp J, Lawrence S, Wadley A, Scott W, George M, Josh J, O’Brien K, Price C, Uebelacker L, Edelman E, Evangeli M, Goodin B, Harding R, Nkhoma K, Parker R, Sabin C, Slawek D, Tsui J, Merlin J. Priorities for HIV and chronic pain research: results from a survey of individuals with lived experience. AIDS Care 2024, ahead-of-print: 1-11. PMID: 38588701, DOI: 10.1080/09540121.2024.2334358.Peer-Reviewed Original ResearchChronic painOptimal management of painSocial health factorsExperience of HIVSymptoms of anxietyManagement of painWeb-based surveyChronic pain researchMultisite painSurvey of individualsHealth factorsPain treatmentTreatment cost-effectivenessUS-based respondentsTask ForceGlobal Task ForceResearch prioritiesSurvey responsesPain researchMedian numberPainHIVOptimal managementTreatment individualizationAddiction treatmentAlcohol-Related Care Among Veterans With Unhealthy Alcohol Use: The Role of Long-Term Opioid Therapy Receipt
Joudrey P, Wang M, DeRycke E, Williams E, Edelman E. Alcohol-Related Care Among Veterans With Unhealthy Alcohol Use: The Role of Long-Term Opioid Therapy Receipt. Journal Of Addiction Medicine 2024, 18: 293-299. PMID: 38533996, PMCID: PMC11150097, DOI: 10.1097/adm.0000000000001291.Peer-Reviewed Original ResearchUnhealthy alcohol useAlcohol-related careLong-term opioid therapyBrief interventionOpioid receiptAlcohol useReceipt of alcohol-related careReceipt of brief interventionVeterans Health Administration careRates of brief interventionDocumented brief interventionNational cohort of veteransWomen Veterans Cohort StudyCohort of veteransPositive alcohol screensAlcohol screeningIntervention receiptAdministration carePositive screenConsumption questionnaireOpioid prescribingNational cohortTherapy receiptCohort studyCarePerspectives regarding cannabis use: Results from a qualitative study of individuals engaged in substance use treatment in Georgia and Connecticut
Warnock C, Ondrusek A, Edelman E, Kershaw T, Muilenburg J. Perspectives regarding cannabis use: Results from a qualitative study of individuals engaged in substance use treatment in Georgia and Connecticut. Drug And Alcohol Dependence Reports 2024, 11: 100228. PMID: 38585142, PMCID: PMC10997993, DOI: 10.1016/j.dadr.2024.100228.Peer-Reviewed Original ResearchSubstance use disordersCannabis useQualitative study of individualsSubstance use disorder treatment outcomesTreatment-related consequencesSemi-structured interviewsSubstance use treatmentSubstance use initiationStudy of individualsImprove healthPrescription medicationsQualitative studyHealth challengesMedicine beliefsPerceived cannabisTreatment cliniciansPeer perceptionsEntering treatmentAt-riskCannabisSocial servicesStudy objectiveYoung adulthoodInterviewsHealthAvailability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium
Lancaster K, Stockton M, Remch M, Wester C, Nash D, Brazier E, Adedimeji A, Finlayson R, Freeman A, Hogan B, Kasozi C, Kwobah E, Kulzer J, Merati T, Tine J, Poda A, Succi R, Twizere C, Tlali M, von Groote P, Edelman E, Parcesepe A, Consortium I. Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. International Journal Of Drug Policy 2024, 124: 104309. PMID: 38228025, PMCID: PMC10939808, DOI: 10.1016/j.drugpo.2023.104309.Peer-Reviewed Original ResearchAlcohol use disorder screeningHIV clinical sitesHIV care settingsProportion of clinicsSubstance use disordersAlcohol use disorderBrief interventionHIV careCare settingsClinical sitesSubstance use disorder screeningTreatment availabilityNegative impact of substance useHIV clinical settingsAvailability of screeningReferral to treatmentInternational epidemiology DatabasesHigh-income countiesImpact of substance useLower-middle-income countriesTreat alcohol use disorderUpper-middle income countriesLow-income countriesEpidemiological databasePrevalence estimatesPerspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care
Soyer E, Frost M, Fletcher O, Ioannou G, Tsui J, Edelman E, Weiner B, Bachrach R, Chen J, Williams E. Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care. Addiction Science & Clinical Practice 2024, 19: 3. PMID: 38200496, PMCID: PMC10782537, DOI: 10.1186/s13722-023-00429-3.Peer-Reviewed Original ResearchConceptsConsolidated Framework for Implementation ResearchAlcohol-related careVeterans Health AdministrationRapid Assessment ProcessClinical stakeholdersPatient participationImplement interventionsBackgroundUnhealthy alcohol useLiver clinicEvidence-based strategiesClinical settingPractice facilitationProvider beliefsImplementation researchHealth AdministrationMethodsData collectionClinical resourcesQualitative interviewsAlcohol use disorderEducation-basedCareAlcohol useMedical CenterPreference-basedRelationship-based
2023
Expanding the Use of Medications for Alcohol Use Disorder: Lessons from the Proliferation of Anti-obesity Medications
Bernstein E, Moreno J, Edelman E. Expanding the Use of Medications for Alcohol Use Disorder: Lessons from the Proliferation of Anti-obesity Medications. Journal Of General Internal Medicine 2023, 39: 1233-1235. PMID: 38087177, PMCID: PMC11116289, DOI: 10.1007/s11606-023-08565-x.Peer-Reviewed Original Research
Clinical Trials
Current Trials
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE)
HIC ID2000030586RolePrincipal InvestigatorPrimary Completion Date02/28/2023Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements and Community Involvement
Clinical Care
Overview
E. Jennifer Edelman, MD, MHS, specializes in HIV and addiction medicine. She provides patient care for HIV/AIDS and its associated complications, such as HIV-associated myopathy, dementia, and neurocognitive disorder.
In addition to her clinical work in HIV care, Dr. Edelman’s research examines substance use disorder treatment in HIV clinics, emergency department-initiated buprenorphine programs, and alcohol reduction interventions for people with HIV.
A recipient of the New England Society of General Internal Medicine Award for Excellence in Clinical Investigation and the Society of General Internal Medicine Lawrence Linn Award, her research has been supported by grants from the National Institutes of Health, the National Institute on Alcohol Abuse and Alcoholism, and the National Cancer Institute.
Dr. Edelman is a professor of medicine at Yale School of Medicine.
Clinical Specialties
Fact Sheets
Opioid Use Disorder
Learn More on Yale MedicineSmoking and Cancer
Learn More on Yale MedicineQuit Smoking
Learn More on Yale MedicineHuman Immunodeficiency Virus (HIV)
Learn More on Yale Medicine
Board Certifications
Addiction Medicine (Internal Medicine)
- Certification Organization
- AB of Addiction Medicine
- Latest Certification Date
- 2024
- Original Certification Date
- 2014
HIV Specialist
- Certification Organization
- American Academy of HIV Medicine
- Latest Certification Date
- 2021
- Original Certification Date
- 2013
Yale Medicine News
Links & Media
News
- May 27, 2024
Unhealthy Alcohol Use Among Men who have Sex with Men Taking PrEP for HIV Prevention
- May 09, 2024
Anderson and Capasso Win Service Excellence Awards
- January 11, 2024
Hidden Dangers of Opioid Epidemic: Study Links Prescribed Opioids to Cardiovascular Disease
- December 21, 2023
ASCI Announces 3 Newly Elected Members From Yale